Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2004 1
2006 2
2007 1
2008 2
2009 3
2010 3
2011 7
2012 2
2013 11
2014 13
2015 9
2016 10
2017 8
2018 13
2019 10
2020 16
2021 24
2022 18
2023 20
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for metformin hydrochloride mh
Your search for metformin-hydrochloridee-r retrieved no results
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
Bramante CT, Huling JD, Tignanelli CJ, Buse JB, Liebovitz DM, Nicklas JM, Cohen K, Puskarich MA, Belani HK, Proper JL, Siegel LK, Klatt NR, Odde DJ, Luke DG, Anderson B, Karger AB, Ingraham NE, Hartman KM, Rao V, Hagen AA, Patel B, Fenno SL, Avula N, Reddy NV, Erickson SM, Lindberg S, Fricton R, Lee S, Zaman A, Saveraid HG, Tordsen WJ, Pullen MF, Biros M, Sherwood NE, Thompson JL, Boulware DR, Murray TA; COVID-OUT Trial Team. Bramante CT, et al. N Engl J Med. 2022 Aug 18;387(7):599-610. doi: 10.1056/NEJMoa2201662. N Engl J Med. 2022. PMID: 36070710 Free PMC article. Clinical Trial.
The adjusted odds ratio for a primary event was 0.84 (95% confidence interval [CI], 0.66 to 1.09; P = 0.19) with metformin, 1.05 (95% CI, 0.76 to 1.45; P = 0.78) with ivermectin, and 0.94 (95% CI, 0.66 to 1.36; P = 0.75) with fluvoxamine. ...The adjusted odds ratio for hos …
The adjusted odds ratio for a primary event was 0.84 (95% confidence interval [CI], 0.66 to 1.09; P = 0.19) with metformin, 1.05 (95% …
Metformin Hydrochloride Mucosal Nanoparticles-Based Enteric Capsule for Prolonged Intestinal Residence Time, Improved Bioavailability, and Hypoglycemic Effect.
Lu W, Yu L, Wang L, Liu S, Li M, Wu Z, Chen S, Hu R, Hao H. Lu W, et al. AAPS PharmSciTech. 2022 Dec 28;24(1):31. doi: 10.1208/s12249-022-02402-w. AAPS PharmSciTech. 2022. PMID: 36577873
Metformin hydrochloride enteric-coated capsule (MH-EC) is a commonly used clinical drug for the treatment of type 2 diabetes. In this study, we described a metformin hydrochloride mucosal nanoparticles enteric-coated capsule (MH-MNPs-EC) …
Metformin hydrochloride enteric-coated capsule (MH-EC) is a commonly used clinical drug for the treatment of type 2 dia …
Liraglutide in Children and Adolescents with Type 2 Diabetes.
Tamborlane WV, Barrientos-Pérez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, Jalaludin MY, Kovarenko M, Libman I, Lynch JL, Rao P, Shehadeh N, Turan S, Weghuber D, Barrett T; Ellipse Trial Investigators. Tamborlane WV, et al. N Engl J Med. 2019 Aug 15;381(7):637-646. doi: 10.1056/NEJMoa1903822. Epub 2019 Apr 28. N Engl J Med. 2019. PMID: 31034184 Clinical Trial.
BACKGROUND: Metformin is the regulatory-approved treatment of choice for most youth with type 2 diabetes early in the disease. However, early loss of glycemic control has been observed with metformin monotherapy. Whether liraglutide added to metformin (with o …
BACKGROUND: Metformin is the regulatory-approved treatment of choice for most youth with type 2 diabetes early in the disease. Howeve …
Potential Enhancement of Metformin Hydrochloride in Lipid Vesicles Targeting Therapeutic Efficacy in Diabetic Treatment.
Ossai EC, Madueke AC, Amadi BE, Ogugofor MO, Momoh AM, Okpala COR, Anosike CA, Njoku OU. Ossai EC, et al. Int J Mol Sci. 2021 Mar 11;22(6):2852. doi: 10.3390/ijms22062852. Int J Mol Sci. 2021. PMID: 33799652 Free PMC article.
The potential enhancement of metformin hydrochloride (MH) loaded in lipid vesicles targeting therapeutic efficacy on alloxan-induced diabetic rats was investigated. ...The metformin hydrochloride-loaded lipid vesicles (MH-LLVs) sustained …
The potential enhancement of metformin hydrochloride (MH) loaded in lipid vesicles targeting therapeutic efficacy on al …
SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
Tang X, Chen XF, Wang NY, Wang XM, Liang ST, Zheng W, Lu YB, Zhao X, Hao DL, Zhang ZQ, Zou MH, Liu DP, Chen HZ. Tang X, et al. Circulation. 2017 Nov 21;136(21):2051-2067. doi: 10.1161/CIRCULATIONAHA.117.028728. Epub 2017 Sep 25. Circulation. 2017. PMID: 28947430 Free PMC article.
Remarkably, the loss of SIRT2 blunted the response of AMPK to metformin treatment in mice infused with Ang II and repressed the metformin-mediated reduction of cardiac hypertrophy and protection of cardiac function. ...Loss of SIRT2 reduces AMPK activation, promotes …
Remarkably, the loss of SIRT2 blunted the response of AMPK to metformin treatment in mice infused with Ang II and repressed the me …
Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis.
Domecq JP, Prutsky G, Leppin A, Sonbol MB, Altayar O, Undavalli C, Wang Z, Elraiyah T, Brito JP, Mauck KF, Lababidi MH, Prokop LJ, Asi N, Wei J, Fidahussein S, Montori VM, Murad MH. Domecq JP, et al. J Clin Endocrinol Metab. 2015 Feb;100(2):363-70. doi: 10.1210/jc.2014-3421. Epub 2015 Jan 15. J Clin Endocrinol Metab. 2015. PMID: 25590213 Free PMC article. Review.
Weight gain was associated with the use of amitriptyline (1.8 kg), mirtazapine (1.5 kg), olanzapine (2.4 kg), quetiapine (1.1 kg), risperidone (0.8 kg), gabapentin (2.2 kg), tolbutamide (2.8 kg), pioglitazone (2.6 kg), glimepiride (2.1 kg), gliclazide (1.8 kg), glyburide (2.6 kg) …
Weight gain was associated with the use of amitriptyline (1.8 kg), mirtazapine (1.5 kg), olanzapine (2.4 kg), quetiapine (1.1 kg), risperido …
Improved synthesis of metformin hydrochloride-sodium alginate (MH-NaALG) microspheres using ultrasonic spray drying.
M A, Gogate PR. M A, et al. Heliyon. 2024 Mar 18;10(6):e28205. doi: 10.1016/j.heliyon.2024.e28205. eCollection 2024 Mar 30. Heliyon. 2024. PMID: 38545196 Free PMC article.
Metformin Hydrochloride (MH), an orally administered antidiabetic drug from the biguanide family, encounters issues of wide particle size distribution, inefficient dissolution rates and short half-life leading to excess dosage which can result in lactic acido …
Metformin Hydrochloride (MH), an orally administered antidiabetic drug from the biguanide family, encounters issues of …
Metformin hydrochloride action on cell membrane N-cadherin expression and cell nucleus revealed by SERS nanoprobes.
Qu X, Qi G, Sun D, Yue J, Xu W, Xu S. Qu X, et al. Talanta. 2021 Sep 1;232:122442. doi: 10.1016/j.talanta.2021.122442. Epub 2021 Apr 30. Talanta. 2021. PMID: 34074427
The anti-tumor effects of metformin hydrochloride (MH), an initial pharmacologic agent for type 2 diabetes, were reexamined by surface-enhanced Raman scattering (SERS) spectroscopy. ...Another AgNP-based nucleus targeting nanoprobe was adopted to culture with …
The anti-tumor effects of metformin hydrochloride (MH), an initial pharmacologic agent for type 2 diabetes, were reexam …
Metformin Hydrochloride Encapsulation by Alginate Strontium Hydrogel for Cartilage Regeneration by Reliving Cellular Senescence.
Xu L, Ma F, Huang J, Frankie Leung KL, Qin C, Lu WW, Guo XE, Tang B. Xu L, et al. Biomacromolecules. 2021 Feb 8;22(2):671-680. doi: 10.1021/acs.biomac.0c01488. Epub 2021 Jan 24. Biomacromolecules. 2021. PMID: 33486954
A previous investigation showed that, by controlling the cellular senescence, the cartilage regeneration can be significantly accelerated. Based on this finding, we design a novel hydrogel, Alg/MH-Sr, that combines metformin, an established drug for inhibiting senes …
A previous investigation showed that, by controlling the cellular senescence, the cartilage regeneration can be significantly accelerated. B …
Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: An adjusted indirect treatment comparison.
Vadher K, Patel H, Mody R, Levine JA, Hoog M, Cheng AY, Pantalone KM, Sapin H. Vadher K, et al. Diabetes Obes Metab. 2022 Sep;24(9):1861-1868. doi: 10.1111/dom.14775. Epub 2022 Jun 13. Diabetes Obes Metab. 2022. PMID: 35589616 Free PMC article.
Aggregate data from the SURPASS-2 study that met the HbA1c inclusion criterion of the SUSTAIN FORTE study and from SUSTAIN FORTE metformin-only treated patients were used for primary analysis. RESULTS: The SURPASS-2 refined population comprised 238/245/240 and 240 particip …
Aggregate data from the SURPASS-2 study that met the HbA1c inclusion criterion of the SUSTAIN FORTE study and from SUSTAIN FORTE metformi …
160 results